Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure

Clinical trial NCT05816733 · UNKNOWN

Trial details

NCT number: NCT05816733
Sponsor: Kun Hua
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Recurrence Cox Maze IV Atrial Fibrillation Patients With or Without Heart Failure and Diabetes

Start date: 2023-09-01
Primary completion: 2024-06-07
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.